| |
Newsroom /
Health and Fitness
/
Health and Fitness
/
United States Anesthesia Drugs Market worth more than 3 Billion by 2018
United States Anesthesia Drugs Market worth more than 3 Billion by 2018
Renub Research (http://renub.com/report/united-states-anesthesia-drugs-market-forecast-155) has announced the addition of the "United States Anesthesia Drugs Market & Forecast
" report to its offerings
Noida,
U.P.,
India
(prbd.net)
04/06/2015
United States Anesthesia Drugs Market- Key Facts Covered
• General intravenous anesthesia drugs market is dominating the United States anesthesia drugs market
• In the United States anesthesia drugs market, Endo Health Solution is the clear leader in 2013
• Baxter is the only company to offer all three of the most commonly used modern inhaled anesthetics for general anesthesia
• Local anesthesia drugs market in United States more than US$ 700 Million in 2013
• Pentobarbital is one of the most common injectable general anesthetic agents used in rodents.
• Propofol and Benzodiazepines Class (Diazepam and Midazolam) are the top contributor intravenous anesthetic drugs in the United States anesthesia drugs market
• Lidocane and Articane are top two leading local anesthetic agents in the United States local anesthetic drugs market
Table of Contents:
1. Executive Summary
2. United States Anesthesia Drugs Market (2010 – 2018)
3. United States Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.1 United States Anesthesia Drugs Market Share & Forecast by Type (2010 – 2018)
3.2 United States General Intravenous Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.3 United States Local Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.4 United States Anesthesia Drugs Market Share & Forecast by Company (2010 – 2018)
4. By Type – United States Anesthesia Drugs Market (2008 – 2018)
4.1 United States General Inhalation Anesthesia Drugs Market (2008 – 2018)
4.2 United States General Intravenous Anesthesia Drugs Market (2008 – 2018)
4.3 United States Local Anesthesia Drugs Market (2008 – 2018)
5. By Drugs – United States General Intravenous Anesthesia Drugs Market (2010 – 2018)
5.1 United States Propofol Market (2010 – 2018)
5.2 United States Benzodiazepines Class (Diazepam and Midazolam) Market (2010 – 2018)
5.3 United States Fospropofol Disodium Market (2010 – 2018)
5.4 United States Ketamine Market (2010 – 2018)
5.5 United States Methohexital Sodium Market (2010 – 2018)
5.6 United States Pentobarbital Market (2010 – 2018)
5.7 United States Etomidate Market (2010 – 2018)
5.8 United States Fentanyl Market (2010 – 2018)
6. By Drugs – United States Local Anesthesia Drugs Market (2008 – 2018)
6.1 United States Articaine Market (2008 – 2018)
6.2 United States Bupivacaine Market (2008 – 2018)
6.3 United States Lidocaine Market (2008 – 2018)
6.4 United States Mepivacaine Market (2008 – 2018)
6.5 United States Prilocaine Market (2008 – 2018)
7. Key Players Profile in United States Anesthesia Drugs Market
7.1 Baxter International Inc. Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.2 Endo Health Solutions Inc. Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.3 Abbott Laboratories Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.4 AstraZeneca Anesthetic Drugs Sales (2009 – 2011)
8. United States Anesthesia Drugs Market – Growth Driver
8.1 Increasing Demand for Anesthesia Service
8.2 Increasing Ageing Population and Prevalence of Cardiovascular Disease in United States
8.2.1 Increasing Ageing Population
9. United States Anesthesia Drugs Market – Challenges
9.1 Shortage of Anesthesia Providers in United States
9.2 Shortage of Anesthesia Drugs in United States
Contact Us
Rajat Gupta
Sr. Manager
Sales & Marketing Div
Renub Research
Email: rajat.gupta@renub.com
Phone: +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India)
Web: http://www.renub.com
About
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automot
|